Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Chardan Healthcare Acquisition 2 Corp - Warrants (05/03/2025) RCORWS

Renovacor Inc is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Its therapeutic focus is on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.

Recent & Breaking News (NYSEAM:RCORWS)

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - OFIX, LMST, PFHD, RCOR

PR Newswire November 17, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCOR, SMBC, TALO, BTRS

PR Newswire November 15, 2022

SHAREHOLDER ALERT: Weiss Law Reminds RCOR, BTRS, AERC, and AKUS Shareholders About Its Ongoing Investigations

PR Newswire November 11, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCKT, RCOR, SMBC, TALO

PR Newswire November 10, 2022

RENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCOR

PR Newswire November 3, 2022

SHAREHOLDER ALERT: Weiss Law Reminds LFG, ECOM, LOTZ, and RCOR Shareholders About Its Ongoing Investigations

PR Newswire November 3, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCOR, SMBC, TALO

PR Newswire November 2, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, RCKT, RMED, RCOR

PR Newswire October 28, 2022

EQUITY ALERT: The M&A Class Action Firm Continues Investigating the Merger - CFCX, BTRS, RCOR, TALO

PR Newswire October 27, 2022

SHAREHOLDER ALERT: Weiss Law Reminds SBTX, RMED, RCOR, and BTRS Shareholders About Its Ongoing Investigations

PR Newswire October 27, 2022

RENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCOR

PR Newswire October 20, 2022

Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress

Business Wire October 10, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STOR, RCKT, RCOR, FCRD

PR Newswire October 6, 2022

SHAREHOLDER ALERT: Weiss Law Reminds AERI, RCOR, STOR, and LOTZ Shareholders About Its Ongoing Investigations

PR Newswire October 5, 2022

SHAREHOLDER ALERT: Weiss Law Reminds RCOR, STOR, AERI, and LOTZ Shareholders About Its Ongoing Investigations

PR Newswire September 28, 2022

Renovacor Announces Upcoming Presentation at Keystone Symposia's Heart Failure: Mechanisms and Therapies Conference

Business Wire September 26, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCOR, SMBC, TALO

PR Newswire September 26, 2022

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Renovacor, Inc. Buyout

Newsfile September 21, 2022

Shareholder Alert: Ademi LLP investigates whether Renovacor, Inc. has obtained a Fair Price in its transaction with Rocket Pharmaceuticals, Inc.

PR Newswire September 21, 2022

SHAREHOLDER ALERT: Weiss Law Investigates Renovacor, Inc.

PR Newswire September 20, 2022